Shobha Reddy

856 total citations
19 papers, 636 citations indexed

About

Shobha Reddy is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Pharmacology. According to data from OpenAlex, Shobha Reddy has authored 19 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Surgery and 6 papers in Pharmacology. Recurrent topics in Shobha Reddy's work include Diabetes Management and Research (12 papers), Diabetes Treatment and Management (11 papers) and Pancreatic function and diabetes (6 papers). Shobha Reddy is often cited by papers focused on Diabetes Management and Research (12 papers), Diabetes Treatment and Management (11 papers) and Pancreatic function and diabetes (6 papers). Shobha Reddy collaborates with scholars based in United States, Germany and Singapore. Shobha Reddy's co-authors include Mary Pat Knadler, Helle Linnebjerg, Michael Skinner, Kenneth Mace, Prajakti A. Kothare, Celedon Gonzales, Soomin Park, R. Lins, Malcolm I. Mitchell and Kwee Poo Yeo and has published in prestigious journals such as Diabetes, Clinical Pharmacology & Therapeutics and Clinical Pharmacokinetics.

In The Last Decade

Shobha Reddy

19 papers receiving 606 citations

Peers

Shobha Reddy
Kwee Poo Yeo Singapore
Deepak Gopal Shewade India
Dwain Tolbert United States
Cynthia J. Harris United States
Małgorzata Wamil United Kingdom
Pablo Zubiaur Spain
Robert L. Roe United States
James F. Burris United States
Chandrasekaran Adithan India
Kevin Shalayda United States
Kwee Poo Yeo Singapore
Shobha Reddy
Citations per year, relative to Shobha Reddy Shobha Reddy (= 1×) peers Kwee Poo Yeo

Countries citing papers authored by Shobha Reddy

Since Specialization
Citations

This map shows the geographic impact of Shobha Reddy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shobha Reddy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shobha Reddy more than expected).

Fields of papers citing papers by Shobha Reddy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shobha Reddy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shobha Reddy. The network helps show where Shobha Reddy may publish in the future.

Co-authorship network of co-authors of Shobha Reddy

This figure shows the co-authorship network connecting the top 25 collaborators of Shobha Reddy. A scholar is included among the top collaborators of Shobha Reddy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shobha Reddy. Shobha Reddy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
3.
Heise, Tim, Helle Linnebjerg, Dachuang Cao, et al.. (2019). 96 - Ultra Rapid Lispro (URLi) Lowers Postprandial Glucose (PPG) and More Closely Matches Normal Physiological Glucose Response Compared to Other Rapid Insulin Analogs. Canadian Journal of Diabetes. 43(7). S36–S36. 3 indexed citations
4.
Linnebjerg, Helle, Qianyi Zhang, Elizabeth LaBell, et al.. (2019). 1107-P: Ultra Rapid Lispro (URLi) Accelerates Insulin Lispro Absorption and Insulin Action vs. Humalog (Lispro) in Patients with T1D. Diabetes. 68(Supplement_1). 9 indexed citations
5.
6.
Leohr, Jennifer, Mary Anne Dellva, David E. Coutant, et al.. (2019). 1100-P: Ultra Rapid Lispro (URLi) Accelerates Insulin Lispro Absorption and Insulin Action vs. Humalog (Lispro) in Patients with T2D. Diabetes. 68(Supplement_1). 8 indexed citations
7.
Kapitza, Christoph, Jennifer Leohr, Rong Liu, et al.. (2018). Ultra-rapid Lispro (URLi) Reduces Postprandial Glucose Excursions vs. Humalog® in Patients with T2D at Multiple Meal-to-Dose Timing Intervals. Diabetes. 67(Supplement_1). 1 indexed citations
8.
Kazda, Christof, Jennifer Leohr, Rong Liu, et al.. (2018). Ultra-rapid Lispro (URLi) Shows Faster Absorption of Insulin Lispro vs. Humalog® during Insulin Pump (CSII) Use in Patients with T1D. Diabetes. 67(Supplement_1). 6 indexed citations
9.
Plum‐Mörschel, Leona, Jennifer Leohr, Rong Liu, et al.. (2018). Ultra-rapid Lispro (URLi) Reduces Postprandial Glucose Excursions vs. Humalog® in Patients with T1D at Multiple Meal-to-Dose Timing Intervals. Diabetes. 67(Supplement_1). 8 indexed citations
10.
Peña, Amparo de la, Mary Seger, Danny Soon, et al.. (2015). Bioequivalence and comparative pharmacodynamics of insulin lispro 200 U/mL relative to insulin lispro (Humalog®) 100 U/mL. Clinical Pharmacology in Drug Development. 5(1). 69–75. 42 indexed citations
11.
Peña, Amparo de la, Kwee Poo Yeo, Helle Linnebjerg, et al.. (2015). Subcutaneous Injection Depth Does Not Affect the Pharmacokinetics or Glucodynamics of Insulin Lispro in Normal Weight or Healthy Obese Subjects. Journal of Diabetes Science and Technology. 9(4). 824–830. 11 indexed citations
12.
Peña, Amparo de la, Xiaosu Ma, Shobha Reddy, et al.. (2014). Application of PK/PD Modeling and Simulation to Dosing Regimen Optimization of High-Dose Human Regular U-500 Insulin. Journal of Diabetes Science and Technology. 8(4). 821–829. 28 indexed citations
13.
Lobo, Evelyn D., Michael Heathman, Shobha Reddy, et al.. (2010). Effects of Varying Degrees of Renal Impairment on the Pharmacokinetics of Duloxetine. Clinical Pharmacokinetics. 49(5). 311–321. 28 indexed citations
14.
Lobo, Evelyn D., Richard F. Bergstrom, Shobha Reddy, et al.. (2008). In Vitro and In Vivo Evaluations of Cytochrome P450 1A2 Interactions with Duloxetine. Clinical Pharmacokinetics. 47(3). 191–202. 64 indexed citations
15.
Linnebjerg, Helle, Prajakti A. Kothare, Soomin Park, et al.. (2007). Effect of renal impairment on the pharmacokinetics of exenatide. British Journal of Clinical Pharmacology. 64(3). 317–327. 142 indexed citations
16.
Kothare, Prajakti A., Helle Linnebjerg, Zachary Skrivanek, et al.. (2007). Exenatide effects on statin pharmacokinetics and lipid response. International Journal of Clinical Pharmacology and Therapeutics. 45(2). 114–120. 30 indexed citations
17.
Suri, Ajit, Shobha Reddy, Celedon Gonzales, et al.. (2005). Duloxetine pharmacokinetics in cirrhotics compared with healthy subjects. International Journal of Clinical Pharmacology and Therapeutics. 43(2). 78–84. 39 indexed citations
18.
Skinner, Michael, Andrej Skerjanec, Mary Seger, et al.. (2003). Effect of age on the pharmacokinetics of duloxetine in women. British Journal of Clinical Pharmacology. 57(1). 54–61. 54 indexed citations
19.
Skinner, Michael, Alan X. Pan, Korbtham Sathirakul, et al.. (2003). Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers. Clinical Pharmacology & Therapeutics. 73(3). 170–177. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kwee Poo Yeo Breakdown of academic impact, for papers by Deepak Gopal Shewade Breakdown of academic impact, for papers by Dwain Tolbert Breakdown of academic impact, for papers by Cynthia J. Harris Breakdown of academic impact, for papers by Małgorzata Wamil Breakdown of academic impact, for papers by Pablo Zubiaur Breakdown of academic impact, for papers by Robert L. Roe Breakdown of academic impact, for papers by James F. Burris Breakdown of academic impact, for papers by Chandrasekaran Adithan Breakdown of academic impact, for papers by Kevin Shalayda
Rankless by CCL
2026